Saver Jeffrey L, Gornbein Jeffrey
UCLA Stroke Center, 710 Westwood Plaza, Los Angeles, CA 90095, USA.
Neurology. 2009 Apr 14;72(15):1310-5. doi: 10.1212/01.wnl.0000341308.73506.b7. Epub 2008 Dec 17.
In acute stroke trials, functional outcome may be analyzed by dichotomizing ordinal outcome scales or by evaluating the entire scale range (shift analysis). The conditions under which shift or binary analysis will be more efficient have not been previously well delineated.
Model randomized clinical trials employing the modified Rankin Scale of global handicap were constructed to reflect 1) mild benefits experienced across all ranges of stroke severity (neuroprotective effect), 2) substantial benefits across all ranges of stroke severity (early recanalization effect), 3) substantial benefits across wide range of stroke severity but with limited ability to achieve fully normal outcome (late recanalization effect), 4) benefits clustered at unexpected health state transitions.
In neuroprotective models, shift analysis was the most efficient technique in detecting a treatment effect. In the early recanalization models, dichotomization at excellent outcome and shift analysis were of comparable efficiency, both superior to dichotomization at good outcome. In the late recanalization models, dichotomization at good outcome performed best, shift analysis less well, and dichotomization at excellent outcome poorly. In the unexpected benefits model, shift analysis substantially outperformed dichotomization analyses. These patterns held among the seven actual acute trials reporting full range Rankin outcomes and showing treatment benefit identified in the literature.
The pattern of treatment effect of the intervention determines whether shift analysis or simple dichotomized analysis will be more efficient. Shift analysis is especially advantageous when treatments confer a relatively uniform, mild benefit to patients over a wide range of stroke severities or confer benefits at unexpected but clinically important health state transitions.
在急性中风试验中,功能结局可通过对有序结局量表进行二分法分析或评估整个量表范围(移位分析)来进行分析。移位分析或二分法分析在何种情况下效率更高,此前尚未得到很好的界定。
构建采用改良Rankin全球残疾量表的模型随机临床试验,以反映1)在所有中风严重程度范围内均有轻度获益(神经保护作用),2)在所有中风严重程度范围内均有显著获益(早期再通作用),3)在广泛的中风严重程度范围内有显著获益,但实现完全正常结局的能力有限(晚期再通作用),4)获益集中在意外的健康状态转变。
在神经保护模型中,移位分析是检测治疗效果最有效的技术。在早期再通模型中,将良好结局进行二分法分析和移位分析的效率相当,均优于将优秀结局进行二分法分析。在晚期再通模型中,将良好结局进行二分法分析效果最佳,移位分析次之,将优秀结局进行二分法分析效果最差。在意外获益模型中,移位分析明显优于二分法分析。这些模式在七项实际的急性试验中也成立,这些试验报告了完整范围的Rankin结局,并显示出文献中确定的治疗获益。
干预措施的治疗效果模式决定了移位分析或简单二分法分析哪种更有效。当治疗在广泛的中风严重程度范围内为患者带来相对一致、轻度的获益,或在意外但具有临床重要性的健康状态转变时带来获益时,移位分析尤其具有优势。